Clinical Trial Update: Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update evaluating cetuximab for advanced unresectable or metastatic chordoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chordoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chordoma, Metastatic Chordoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING